NCT07091968 Feasibility of a Technology-Based Intervention for Depression Referral Uptake in Cancer Survivors
| NCT ID | NCT07091968 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-16 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-16 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Depression is very common in cancer survivors but there are challenges to linking those in need of treatment efficiently to care. In this study, investigators will test the feasibility and acceptability of a new text-based approach to connect cancer survivors with depression with care.
Eligibility Criteria
Inclusion Criteria: * age \> 18 years * diagnosis of cancer * upcoming appointment in an HCC or HCN oncology clinic within 14 days * English proficiency * ownership of a cellphone with SMS text capability. * elevated depressive symptoms at screening (as measured by \> 3 on the PHQ-2) Exclusion Criteria: * cognitive impairment as evaluated by attending physician * currently receiving counseling for depression
Contact & Investigator
Katherine Sterba, PhD
PRINCIPAL INVESTIGATOR
Medical University of South Carolina
Frequently Asked Questions
Who can join the NCT07091968 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07091968 currently recruiting?
Yes, NCT07091968 is actively recruiting participants. Contact the research team at lir301@musc.edu for enrollment information.
Where is the NCT07091968 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT07091968 clinical trial?
NCT07091968 is sponsored by Medical University of South Carolina. The principal investigator is Katherine Sterba, PhD at Medical University of South Carolina. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.